These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 12388535)

  • 1. Gadolinium diffusion into orbital vitreous and aqueous humor, perivascular space, and ventricles in patients with chronic renal disease.
    Kanamalla US; Boyko OB
    AJR Am J Roentgenol; 2002 Nov; 179(5):1350-2. PubMed ID: 12388535
    [No Abstract]   [Full Text] [Related]  

  • 2. High signal in the cerebrospinal fluid following prior gadolinium administration in a patient with renal impairment.
    Ong EM; Yeh IB
    Singapore Med J; 2007 Nov; 48(11):e296-8. PubMed ID: 17975681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Controlled drug release from an ocular implant: an evaluation using dynamic three-dimensional magnetic resonance imaging.
    Kim H; Robinson MR; Lizak MJ; Tansey G; Lutz RJ; Yuan P; Wang NS; Csaky KG
    Invest Ophthalmol Vis Sci; 2004 Aug; 45(8):2722-31. PubMed ID: 15277497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gadolinium encephalopathy in a patient with renal failure.
    Maramattom BV; Manno EM; Wijdicks EF; Lindell EP
    Neurology; 2005 Apr; 64(7):1276-8. PubMed ID: 15824364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Persistence of gadolinium in CSF: a diagnostic pitfall in patients with end-stage renal disease.
    Rai AT; Hogg JP
    AJNR Am J Neuroradiol; 2001 Aug; 22(7):1357-61. PubMed ID: 11498427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Diffusion of fosfomycin into the human and rabbit eye (aqueous humor and vitreous body)].
    Denis F; Adenis JP; Mounier M; Monassier M
    Pathol Biol (Paris); 1986 May; 34(5):357-9. PubMed ID: 3534706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pharmacokinetics of gadolinium-DTPA in chronic renal insufficiency requiring dialysis].
    Krahe T; Götz R; Lackner K; Haustein J; Klemenz U; Landwehr P; Heidbreder E; Schuhmann-Giampieri G
    Rofo; 1992 Jun; 156(6):523-6. PubMed ID: 1617171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subarachnoid gadolinium enhancement mimicking subarachnoid hemorrhage on FLAIR MR images. Fluid-attenuated inversion recovery.
    Lev MH; Schaefer PW
    AJR Am J Roentgenol; 1999 Nov; 173(5):1414-5. PubMed ID: 10541135
    [No Abstract]   [Full Text] [Related]  

  • 9. Fibrinolytic activity and localization of plasminogen activator in bovine vitreous body and aqueous humor.
    Hayashi K; Nakashima Y; Sueishi K; Tanaka K
    Jpn J Ophthalmol; 1989; 33(1):66-75. PubMed ID: 2499726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gadolinium-enhanced imaging of liver tumors and manifestations of hepatitis: pharmacodynamic and technical considerations.
    Sharma P; Kitajima HD; Kalb B; Martin DR
    Top Magn Reson Imaging; 2009 Apr; 20(2):71-8. PubMed ID: 20010061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Acid-base status of the intraocular media in diabetics].
    Bezpal'chiĭ AN; Glinchuk IaI; Makhacheva ZA
    Vestn Oftalmol; 1986; 102(5):59-61. PubMed ID: 3787949
    [No Abstract]   [Full Text] [Related]  

  • 12. Nephrogenic systemic fibrosis and gadolinium-based contrast: what's a nephrologist to do?
    Perazella MA
    Semin Dial; 2008; 21(2):121-2. PubMed ID: 18248521
    [No Abstract]   [Full Text] [Related]  

  • 13. [Nicotinic acid metabolism in crystalline lens, aqueous humor and in vitreous body].
    CIUSA W; CRISTINI G; GARUTTI MA
    Klin Monbl Augenheilkd Augenarztl Fortbild; 1957; 130(4):488-91. PubMed ID: 13450214
    [No Abstract]   [Full Text] [Related]  

  • 14. [Intraocular penetration of pefloxacin in man and rabbit. The aqueous humor and vitreous body].
    Denis F; Mounier M; Adenis JP
    Pathol Biol (Paris); 1987 Jun; 35(5 Pt 2):772-6. PubMed ID: 3309813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Changes in glycolysis metabolites and enzyme activities in the vitreous body and aqueous humor of incubated calf eyes].
    Wurster U; Hoffmann K
    Ber Zusammenkunft Dtsch Ophthalmol Ges; 1977; 74():682-6. PubMed ID: 577807
    [No Abstract]   [Full Text] [Related]  

  • 16. NSF-active and NSF-inert species of gadolinium: mechanistic and clinical implications.
    Kuo PH
    AJR Am J Roentgenol; 2008 Dec; 191(6):1861-3. PubMed ID: 19020260
    [No Abstract]   [Full Text] [Related]  

  • 17. Free gadolinium is a likely trigger of nephrogenic systemic fibrosis.
    Abraham JL; Edward M
    AJR Am J Roentgenol; 2009 Oct; 193(4):W354; author reply W355. PubMed ID: 19770307
    [No Abstract]   [Full Text] [Related]  

  • 18. The gadolinium complexes with polyoxometalates as potential MRI contrast agents.
    Li Z; Li W; Li X; Pei F; Li Y; Lei H
    Magn Reson Imaging; 2007 Apr; 25(3):412-7. PubMed ID: 17371733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High prevalence of nephrogenic systemic fibrosis in chronic renal failure patients exposed to gadodiamide, a gadolinium-containing magnetic resonance contrast agent.
    Rydahl C; Thomsen HS; Marckmann P
    Invest Radiol; 2008 Feb; 43(2):141-4. PubMed ID: 18197066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Studies of the penetrating ability of fosfomycin into the aqueous humor and vitreous body of the eye].
    Philipp W; Kofler J
    Klin Monbl Augenheilkd; 1986 Sep; 189(3):240-2. PubMed ID: 3784414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.